hims hers novo nordisk - Search News

News

Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers

Insider on MSN · 2d

Hims & Hers stock plunges after Novo Nordisk ends its brief partnership

The Danish pharmaceutical said it was ending the partnership because Hims is selling and promoting a cheaper copycat of its blockbuster drug Wegovy.

CNBC on MSN · 2d

Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 34%

Novo Nordisk said Hims & Hers has "failed to adhere to the law which prohibits mass sales of compounded drugs" under the "false guise" of personalization.

The Motley Fool on MSN · 1d

Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers: Here's What Investors Need to Know

Novo Nordisk alleged that Hims & Hers is putting patient safety at risk by selling compounded versions of Wegovy. Novo's ending of its deal with Hims & Hers jeopardizes the healthcare platform's goal to lead the weight loss market.

2don MSN

Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the ...

1d

Long Island experts weigh in after Novo Nordisk ends deal with Hims & Hers over weight loss meds

Novo Nordisk had been providing Hims & Hers with the FDA-approved Wegovy, an injectable semaglutide used for weight loss ...

21h

Hims & Hers: Panic Sell Or Opportunistic Buy?

The breakup between Hims & Hers and Novo Nordisk has hit HIMS stock hard with a 35% crash. Click here for a full investment ...

2don MSN

Why Hims & Hers Health Stock Is Crashing Today

The loss of its ability to sell Wegovy is a significant hit to Hims & Hers' business. The massive drop today in its stock ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results